Novartis MS drug cuts relapse rate by half compared to Sanofi medicine
The company plans to start asking health authorities for approvals by year’s end
Novartis’s investigational multiple sclerosis…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sanofi
Sanofi and Regeneron get EU approval for Dupixent
European Commission has extended marketing authorisation for Dupixent European Union to include adolescents 12 to 17 years of age…
FEEDBACK TO FDD Conclave 2019
FDD Conclave 2019, Dr Ramesh Jhawar, Ajanta Pharma , Sapna Ramesh, Indoco Remedies,
ravikumar n, MSN Labortories, ulhas Dhuppad,…
Merial and Zoetis in strategic agreement
Agreement expands Merial portfolio to include 15 new products, making it a key player in the dairy cattle market in India
Sanofi and Innate Pharma collaborate
Research collaboration and licensing agreement for new bispecific antibodies will use Innate Pharma's and Sanofi's technology to…
Dengvaxia first dengue vaccine approved in Brazil
With 1.4 million dengue cases reported this year, Brazil stands to gain tremendous value from this new dengue prevention tool…
Dengue vaccine Dengvaxia approved in Mexico
First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic…
Sanofi teams up with Evotec, Apeiron
To develop immuno-oncology pills
Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to…
Sanofi appoints Suresh Kumar to Executive Committee
He will take the position as Executive Vice President and External Affairs
Sanofi appointed Suresh Kumar as a new member of the…
Big Pharma drives innovation in pain therapy development, despite declining patent applications
Patent applications for pain treatments between 2008 and 2012 were dominated by Big Pharma, including Sanofi, Novartis and Merck…